Calvert Management

 

Employing an impressive team of highly qualified industry experts and staff, we provide our customers with years of unprecedented real world experience in the pharmaceutical and biotechnology fields.


 

Allan N. Reiss
President & Chief Executive Officer

Al is President and Chief Executive Officer of Calvert Laboratories, Inc. He has been an active member of the lab's management team since 2000 and is largely responsible for the complete operations and financial activities of the company.

Al came to Calvert following a successful international management-consulting career that took him throughout the world and across many industry groups.

Living primarily in Florida, Al has superb weather in which to ride his custom Black Cherry Black Pearl Harley-Davidson. Al is also an accomplished competitive power-lifter.

 

Charles B. Spainhour, V.M.D., Ph.D., DABFS, DABT, DABFM
Chief Scientific Officer

Bart has complete daily operational, scientific and regulatory responsibility for Calvert Laboratories. Dr. Spainhour has been with Calvert Labs since Calvert Holdings acquired the Laboratory from MDS Pharma Services in early 2000. Previously, Bart was with Pharmakon Research International, Chrysalis International and Phoenix International Life Sciences.

Dr. Spainhour has amassed approximately thirty-eight years of experience in the pharmaceutical industry. For his first fifteen years Bart was employed at a company (Smith Kline & French Laboratories) that has now evolved into GlaxoSmithKline Corp., where Bart held positions in both the research and the development segments of the drug development timeline. Specifically, on the research side Dr. Spainhour’s activities involved the areas of phosphodiesterase inhibition, anti-diuretic hormone agonism and antagonism, dopamine agonism and antagonism, neuroleptic biochemistry, anti-infective mechanisms and structure-activity-relationships. On the development, side Bart worked in pharmacokinetics & metabolism, radiosynthesis, process chemistry and drug safety evaluation. Specific areas of endeavor included H2-antagonists, leukotrienes, anti-infectives, anti-hypertensives, anti-hyperglycemic agents and anti-arrhythmics. Dr. Spainhour has a great interest and copious amount of experience in the research and development of natural products. Bart has also spent time as an independent consultant in the areas of safety assessment and forensic toxicology, held a position on the faculty at the veterinary school of Texas A & M University and worked as a Toxicologist in other contract research organizations.

Dr. Spainhour holds a veterinary degree from the University of Pennsylvania and a Ph.D. from Texas A & M University (Developmental Toxicology). In his spare time Bart enjoys gardening, photography, cabinet-making and field trial training his Labrador Retrievers.

 

Leslie Maas

Vice President, Client Services 

Leslie Maas joined Calvert Laboratories, Inc. (formerly Pharmakon Research) in January of 1977 as a pharmacology technician.  She became the Quality Assurance Unit Leader shortly thereafter and was the Quality Assurance Manager from 1980-1987.  She then took the position of Manager of Client Services and Operations for 14 years. 

She then became Manager of Marketing from 2000-2003 and was promoted to Director, Client Services in 2004.  In 2006 she became Vice President, Client Services and is presently responsible for serving the clients with information they request such as pricing, protocols, literature, contracts and schedules of studies and also does some project management.  She keeps track of ongoing studies, inquiries and acquisitions, does follow-up with clients. She works closely with the financial group of Calvert on pricing and revenue recognition.  She also is responsible for preparation of exhibits at shows. 

Leslie received her bachelor’s degree in mathematics from the University of Mississippi in 1976. 

Les drives around in her Alfa Romeo in the summer.  When she’s not in her Alfa she’s in her back yard gardening.  She enjoys swimming, biking, hiking and cross country skiing.  If you twist her arm she’ll even play a game of golf.

 

Jill L. Fogleman, PH.D.

Vice President, General Toxicology

Dr. Jill (Zeiders) Fogleman joined Calvert Laboratories, Inc. in 1999 as a Scientist/Study Director in Toxicology.  During her time at Calvert she has been responsible for directing acute and sub-chronic toxicology studies in a variety of species, protocol development, interaction with clients, data evaluation and report writing.  She was promoted to Associate Director of Toxicology in 2001.  In this role she oversaw the day-to-day running of the department.  In addition, Jill was also responsible for the validation and implementation of telemetry studies for use in safety pharmacology studies. She was promoted to Vice President in January 2006. In addition to continuing her work as a toxicology study director she is responsible for the PK/ADME, pharmacy, and metrology departments at Calvert.

Jill received her bachelor’s degree in biochemistry from Susquehanna University in 1995.  She then went on to graduate school at Duke University where she received her Ph.D. in pharmacology in 1999.  Her graduate work focused on the ontogeny of cardiac b-adrenoceptor desensitization which resulted in four major research papers published in the Journal of Pharmacology and Experimental Therapeutics (JPET) and the Journal of Molecular and Cellular Cardiology.

Jill enjoys gardening, cooking and playing volleyball.

 

Darlene Gilpin, B.S., RQAP-GLP

Director, Quality Assurance 

Darlene Gilpin joined Calvert Laboratories in September, 1996 as a Research Associate in the Toxicology department. After gaining experience at the technical level and as a report writer, Darlene moved into the Quality Assurance Unit in 1999. In October, 2004 Darlene was promoted to Manager, Quality Assurance and in January, 2006 Darlene was promoted to Director Quality Assurance where she is responsible for the overall direction of the Quality Assurance Unit. 

During her tenure at Calvert Laboratories, Darlene has become an active member in the Society of Quality Assurance (SQA), Mid-Atlantic Society of Quality Assurance (MARSQA) and the GLP Specialty Section of SQA. In 2002, she became certified as a Registered Quality Assurance Professional in GLP through the SQA.  Darlene obtained her B.S. in Dairy & Animal Science from the Pennsylvania State University in 1995.

 

Daniel Norton, Ph.D.
Director, Experimental Toxicology

Dan is a native of Northeastern Pennsylvania and was a Louisiana State University Ph.D. transplant during his graduate education where he trained as a molecular virologist prior to coming ‘home’ to Calvert in October of 2000. Learning all along the way as a Study Director in the toxicology department, the exposure to the disciplines of toxicology and pharmacology have enriched his scientific knowledge in the field of drug development. In time, opportunities to manage departmental affairs and staff have been a welcome additional challenge to his daily activities. Being able to work with dedicated, good people on a daily basis is a rewarding aspect of his job.

In his spare time, spending time with family and friends and watching sports lets him relax and keeps him grounded.

 

Steve Sloneker
Director, Pharmacokinetics & ADME

Steve Sloneker joined Calvert Laboratories, Inc. in September of 1991 (the company was known as Pharmakon Research International then) as a Senior Associate Scientist in the newly created department of pharmacokinetics.  Over the years to 1997, Steve became a Scientist, Study Director, and Supervisor of the pharmacokinetic staff.  In 2000, Steve was promoted to Associate Director, Pharmacokinetics and ADME.  He directs, designs, executes, analyzes, and summarizes all aspects of preclinical pharmacokinetic and toxicokinetic in vivo studies.  He serves as a Principal Investigator and liason for analytical services for Calvert Laboratories.  In 2007, Steve was promoted to Director.  He regularly attends the annual meeting for the American Association of Pharmaceutical Scientists and Society of Toxicology.

Steve received his bachelor’s degree in biology from Centre College of Kentucky in 1977 and became a Graduate Fellow in 1978 as an assistant to the Dean of Students and Science Division.  In the following years, Steve conducted research for the Tobacco and Health Institute and College of Pharmacy at the University of Kentucky.  Later, Steve was a graduate student in the Pharmaceutical Sciences program there and performed research and served as a teaching assistant.

Steve enjoys professional and college sports, thoroughbred horse racing, golf, and preparing dinner for his family.

 

Daniel Clark, A.S.
Associate Director of IT

Dan Clark joined Calvert Laboratories, Inc. in September, 2004 as their IT Specialist. In January, 2006 Dan was promoted to Manager of IT and then in September, 2007 he was promoted to Associate Director of IT.  Dan is responsible for maintaining all data, network, security, and software related functions at Calvert Laboratories, Inc.

Dan received his Associates of Science degree in Computer Information Technology from Johnson College, Scranton, PA in 2003 and is currently pursuing a Bachelors degree in Computer Information Technology from the Keystone College, LaPlume, PA.  Dan is also working towards certificates for Microsoft’s MCSE.

In his spare time, Dan is very active in coaching his sons’ baseball teams and enjoys playing softball, golf and shooting darts with his wife and brother.

 

Laurie M. Serfilippi, VMD, DACLAM
Director of Laboratory Animal Medicine

Laurie M. Serfilippi graduated from Albright College in 1985 magna cum laude with a BS in Biochemistry and from the University of Pennsylvania, School of Veterinary Medicine in 1989 summa cum laude. She became a Diplomate in the American College of Laboratory Animal Medicine in 2005. She is licensed to practice veterinary medicine in Pennsylvania and New York and USDA accreditated in Pennsylvania. She began her my career in a mixed animal veterinary practice with an emphasize in bovine medicine and surgery.  She has been with the company since 1991.  From 1991 until 1995 she was a subchronic/chronic toxicology study director and staff veterinarian. From 1996 to 1998 she pursued other avenues of my career as a veterinarian working in the pet food industry, teaching at a local veterinary technician program and running her own equine practice.  She returned to Calvert in 1999 to the present initially as the attending veterinarian and subsequently became the Director of Laboratory Animal Medicine.

Laurie’s primary responsibility is the health and welfare of the animals at Calvert. This responsibility encompasses a very diversified variety of activities such as animal welfare, care and use, regulatory compliance, study director education, SOP development, technique development, training, pathology and clinical pathology oversight, facility maintenance guidance, surgical procedures, anesthesia, etc.  

Extracurricular activities include church, house building, Secretary-Treasurer for the Northeastern Pennsylvania Veterinary Medical Association, answering employee pet related questions, cross stitching, gardening, hiking, and bicycling.

 

Joan M. Chapdelaine, Ph.D.
Vice President, Immunology

Dr. Joan M. Chapdelaine received her B.S. in Microbiology from the University of Rhode Island and her Ph.D. in Genetics from the Albert Einstein College of Medicine. After completing a Post-Doctoral fellowship in Immunology at the University of Pennsylvania School of Medicine as a Damon Runyon-Walter Winchell Cancer Fund Fellow, she joined the Immunology Department at Wyeth-Ayerst Research working in the area of Immunoregulation and Rheumatoid Arthritis.

In 1988 Dr. Chapdelaine joined Calvert (formerly Pharmakon), where she established the Immunology Department. She is currently Vice President of Immunology and is responsible for both Immunotoxicology and Immunopharmacology.

Dr Chapdelaine has over 30 years experience in Immunology. She presently oversees all the inflammatory/autoimmune disease models as well as studies such as the local lymph node assay and T-dependent antibody response assay to KHL for immunotoxicology evaluation. Dr Chapdelaine has also participated in an Inter-laboratory evaluation of a modified Local Lymph Node Assay for the assessment of sensitization of systemically administered test articles in which 11 different laboratories participated including the FDA.

Dr. Chapdelaine is a member of several professional organizations including the Society of Toxicology (SOT), American College of Toxicology (ACT), American College of Rheumatology (ACR) and the Inflammation Research Association (IRA). She has served as a board member, secretary and registrar for the IRA.

During her free time, Joan enjoys gardening including her water garden complete with Koi, reading, and good wine.

 

Thomas L. Ferrell, B.S., RLATG
Manager, Laboratory Animal Resources/Primatology

Thomas Ferrell joined Calvert (then Pharmakon) in 1996 bringing with him over 25 years of experience in research facility management with the emphasis on the husbandry and toxicology of nonhuman primates.

Mr. Ferrell initiated and oversees all primate activities at Calvert. In addition he co-chairs the Institutional Animal Care and Use Committee (IACUC), supervises Pathology activities and is the point of contact for numerous vendors and regulatory agencies.

Active within The American Association for Laboratory Animal Science (AALAS), Tom sits on their Editorial Review Board and serves on the faculty of The Institute for Laboratory Animal Management.

Mr. Ferrell received his B.S. from Michigan State University and his Laboratory Animal Technologist certification while at the U.S. Air Force School of Aerospace Medicine.

In his spare moments, Tom has an interest in a pre-1920 classic car restoration facility

 

 

 

calvert holdings corporation  |  copyright 2003  |  all rights reserved